Scale 27B, is making significant strides in cancer therapy research. Meanwhile, Blaise Agüera y Arcas discusses the evolving intersections of AI.

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Scientists discover that loss of MTAP gene disables immune defenses in tumors; DFMO drug could reactivate STING pathway.

Peginterferon-α treatment exhibits low rates of the serological conversion rate of hepatitis B e antigen (HBeAg) and the ...

Researchers evaluated whether interferon-α nasal spray reduces the incidence of COVID-19 or other respiratory viral infections among adults with cancer.

In the current study, the association between mRNA COVID vaccination and survival was strongest among patients whose tumors ...

While the AI world is busy pitching visions of utopia, Google’s lab lights remain on, deep into the night While others love grandstanding about “solving world hunger” or “curing cancer,” Google ...

Trageting abnormal brain cells linked to chronic inflammation may be key to treating people with progressive forms of MS, a ...

Saphnelo can now be administered subcutaneously rather than intravenously following the European regulator’s recommendation.

Interferon lambda concentrations in nasal lining fluid fell in or above the predicted therapeutic range with a nasally ...

Results of a study led by researchers at Roswell Park Comprehensive Cancer Center are shedding light on why some newly ...

DNTH212 is a bifunctional fusion protein targeting plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while ...